Vanguard Group’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.27B Sell
10,380,896
-30,586
-0.3% -$3.75M 0.02% 592
2025
Q1
$1.05B Buy
10,411,482
+7,401
+0.1% +$750K 0.02% 626
2024
Q4
$961M Buy
10,404,081
+138,196
+1% +$12.8M 0.02% 674
2024
Q3
$992M Buy
10,265,885
+24,451
+0.2% +$2.36M 0.02% 667
2024
Q2
$879M Buy
10,241,434
+75,287
+0.7% +$6.46M 0.02% 689
2024
Q1
$840M Buy
10,166,147
+169,113
+2% +$14M 0.02% 723
2023
Q4
$667M Buy
9,997,034
+450,081
+5% +$30M 0.01% 811
2023
Q3
$641M Buy
9,546,953
+31,380
+0.3% +$2.11M 0.02% 777
2023
Q2
$644M Sell
9,515,573
-377,399
-4% -$25.6M 0.02% 781
2023
Q1
$535M Buy
9,892,972
+143,531
+1% +$7.77M 0.01% 865
2022
Q4
$583M Buy
9,749,441
+96,261
+1% +$5.76M 0.02% 783
2022
Q3
$437M Sell
9,653,180
-2,340,404
-20% -$106M 0.01% 905
2022
Q2
$535M Buy
11,993,584
+199,672
+2% +$8.9M 0.02% 818
2022
Q1
$667M Sell
11,793,912
-40,201
-0.3% -$2.27M 0.02% 802
2021
Q4
$614M Buy
11,834,113
+66,173
+0.6% +$3.44M 0.01% 869
2021
Q3
$703M Buy
11,767,940
+64,073
+0.5% +$3.83M 0.02% 790
2021
Q2
$727M Buy
11,703,867
+158,527
+1% +$9.84M 0.02% 787
2021
Q1
$752M Buy
11,545,340
+234,562
+2% +$15.3M 0.02% 737
2020
Q4
$744M Buy
11,310,778
+54,861
+0.5% +$3.61M 0.02% 698
2020
Q3
$582M Sell
11,255,917
-926,513
-8% -$47.9M 0.02% 709
2020
Q2
$600M Sell
12,182,430
-380,020
-3% -$18.7M 0.02% 681
2020
Q1
$640M Buy
12,562,450
+136,473
+1% +$6.95M 0.03% 580
2019
Q4
$685M Buy
12,425,977
+66,981
+0.5% +$3.69M 0.02% 674
2019
Q3
$622M Buy
12,358,996
+258,920
+2% +$13M 0.02% 696
2019
Q2
$610M Sell
12,100,076
-179,859
-1% -$9.07M 0.02% 707
2019
Q1
$571M Buy
12,279,935
+171,771
+1% +$7.98M 0.02% 729
2018
Q4
$594M Buy
12,108,164
+436,195
+4% +$21.4M 0.03% 632
2018
Q3
$724M Buy
11,671,969
+252,519
+2% +$15.7M 0.03% 626
2018
Q2
$615M Buy
11,419,450
+56,791
+0.5% +$3.06M 0.03% 675
2018
Q1
$517M Buy
11,362,659
+256,891
+2% +$11.7M 0.02% 744
2017
Q4
$437M Buy
11,105,768
+41,346
+0.4% +$1.63M 0.02% 813
2017
Q3
$408M Buy
11,064,422
+1,596,125
+17% +$58.9M 0.02% 813
2017
Q2
$365M Buy
9,468,297
+412,398
+5% +$15.9M 0.02% 862
2017
Q1
$308M Buy
9,055,899
+400,504
+5% +$13.6M 0.02% 932
2016
Q4
$284M Buy
8,655,395
+526,609
+6% +$17.3M 0.02% 944
2016
Q3
$262M Buy
8,128,786
+178,397
+2% +$5.76M 0.02% 929
2016
Q2
$246M Buy
7,950,389
+214,346
+3% +$6.62M 0.02% 935
2016
Q1
$232M Buy
7,736,043
+164,334
+2% +$4.92M 0.02% 948
2015
Q4
$210M Buy
7,571,709
+189,953
+3% +$5.26M 0.01% 970
2015
Q3
$225M Buy
7,381,756
+206,720
+3% +$6.31M 0.02% 928
2015
Q2
$263M Buy
7,175,036
+517,543
+8% +$19M 0.02% 894
2015
Q1
$235M Buy
6,657,493
+232,074
+4% +$8.19M 0.02% 948
2014
Q4
$197M Buy
6,425,419
+126,126
+2% +$3.86M 0.01% 985
2014
Q3
$185M Buy
6,299,293
+50,872
+0.8% +$1.49M 0.01% 981
2014
Q2
$178M Buy
6,248,421
+52,731
+0.9% +$1.5M 0.01% 1042
2014
Q1
$177M Buy
6,195,690
+153,178
+3% +$4.38M 0.01% 995
2013
Q4
$160M Buy
6,042,512
+324,178
+6% +$8.59M 0.01% 1028
2013
Q3
$157M Buy
5,718,334
+169,094
+3% +$4.64M 0.02% 971
2013
Q2
$127M Buy
+5,549,240
New +$127M 0.01% 1011